相关实验视频
Updated: Jul 27, 2025

05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
37.5K
在使用SSRI/SNRI抗抑郁药期间和之后减弱了psilocybin效应
Natalie Gukasyan1, Roland R Griffiths1, David B Yaden1
1Department of Psychiatry and Behavioral Sciences, Center for Psychedelic and Consciousness Research, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Journal of psychopharmacology (Oxford, England)
|June 9, 2023
概括
常见的抗抑郁药物,如SSRI/SNRIs,可能会降低 псилоцибин的作用. 在停止服用这些药物后,这种相互作用可能持续长达三个月,影响了迷幻疗法研究.
科学领域:
- 心理药理学 心理药理学
- 神经科学是一个神经科学.
- 临床心理学 临床心理学
背景情况:
- 西在治疗抑郁症方面表现有前途.
- 西和常见抗抑郁药之间的相互作用尚未得到充分了解.
- 初步数据表明,色胺抗抑郁药可能会降低西宾的效果.
研究的目的:
- 为了研究抗抑郁药如何影响 псилоцибин的疗效.
- 为了确定同时使用抗抑郁药是否会减轻西宾的作用.
- 评估抗抑郁药停用对西影响的影响.
主要方法:
- 进行了一项在线追溯调查.
- 参与者报告了他们与抗抑郁药一起或停止服用抗抑郁药后使用psilocybin.
- 收集的数据包括相对于预期的感知药物效应强度.
主要成果:
- 选择性色素再吸收抑制剂 (SSRI) 和色素和上腺素再吸收抑制剂 (SNRIs) 与比预期更弱的色素效应有关.
- 与SSRI/SNRIs相比,布鲁的减弱西宾效应的可能性较低.
- 在停止SSRI/SNRI治疗后,降低了psilocybin的效果持续了3-6个月.
结论:
- 似乎SSRI和SNRIs减轻了psilocybin的主观作用.
- 这些抗抑郁药对西的抑制作用可能在停止服用后持续几个月.
- 这些发现对心理辅助治疗方案和患者选择有影响.
相关概念视频
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
453
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
453
Antidepressant Drugs: MAOIs and Other Agents
281
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
281
Antidepressant Drugs: Overview
607
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
607
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
211
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
211
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
317
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
317
Desensitization and Tachyphylaxis
1.9K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.9K

